Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2011-02-08
2011-02-08
Hui, San-ming (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
active
07884135
ABSTRACT:
Methods and compositions comprising modafinil are described for treating premature ejaculation in a male individual.
REFERENCES:
patent: 4177290 (1979-12-01), Lafon
patent: 4927855 (1990-05-01), Lafon
patent: 5612379 (1997-03-01), Laurent
patent: 5700478 (1997-12-01), Biegajski et al.
patent: 6177096 (2001-01-01), Zerbe et al.
patent: RE37516 (2002-01-01), Grebow et al.
patent: 6348500 (2002-02-01), Fu
patent: 6465519 (2002-10-01), Fu
patent: 6489363 (2002-12-01), Jacobs et al.
patent: 6552024 (2003-04-01), Chen et al.
patent: 6756051 (2004-06-01), Chen et al.
patent: 6875893 (2005-04-01), Largeau et al.
patent: 2001/0034373 (2001-10-01), Miller et al.
patent: 2002/0098240 (2002-07-01), Jacobs et al.
patent: 2003/0171439 (2003-09-01), Lawyer et al.
patent: 2004/0105891 (2004-06-01), Bentolila et al.
patent: 2004/0170683 (2004-09-01), Sherman
patent: 2004/0229942 (2004-11-01), Hassman et al.
patent: 2006/0241320 (2006-10-01), Neckebrock et al.
patent: 2006/0252835 (2006-11-01), Broquaire et al.
patent: 2007/0021510 (2007-01-01), Hickey et al.
patent: 2007/0065517 (2007-03-01), Heacock et al.
patent: 2007/0293702 (2007-12-01), Braude et al.
patent: 2008/0031939 (2008-02-01), Braude et al.
patent: 2008/0058424 (2008-03-01), Covari et al.
patent: 1 291 016 (2003-03-01), None
patent: WO 02/30413 (2002-04-01), None
patent: WO 2006/032146 (2006-03-01), None
patent: WO 2007/013962 (2007-02-01), None
Waldinger et al., J. Sex. Med, 2005;2:121-131.
Ninan et al., Journal of Clinical Psychiatry, 2004;65(3):414-420 (Abstract only).
International Preliminary Report on Patentability for international application No. PCT/US2007/017948 (Feb. 26, 2009).
International Preliminary Search Report for international application No. PCT/US2007/017948 (Jul. 3, 2008).
Written Opinion of the International Searching Authority for international application No. PCT/US2007/017948 (Jul. 3, 2008).
Bi et al., Preparation and Evaluation of a Compressed Tablet Rapidly Disintegrating in the Oral Cavitiy,Chem. Pharm. Bull. (Tokyo), 44: 2121-2127 (1996).
Birudaraj et al., Buccal Permeation of Buspirone: Mechanistic Studies on Transport Pathways,J. Pharm. Sci., 94: 70-78 (2005).
Cilurzo et al., Fast-dissolving mucoadhesive microparticulate delivery system containing piroxicam,Eur. J. Pharm. Sci., 24(4): 355-361 (2005).
Dinges et al., Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss,Curr. Medical Research and Opinions, 22: 159-167 (2006).
Donovan et al., Chiral Analysis ofd- andl-Modafinil in Human Serum: Application to Human Pharmacokinetic Studies,Ther. Drug. Monit., 25(2): 197-202 (2003).
Duteil et al., Centralx/-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals,Eur. J. Pharmacol., 180: 49-58 (1990).
Fu et al., Orally Fast Disintegrating Tablets: Developments, Technologies, Tast-Masking and Clinical Studies,Crit. Rev. Ther. Drug Carrier Syst., 21(6): 433-475 (2004).
Hass et al., Developments in the area of bioadhesive drug delivery systems,Expert Opin. Biol. Ther., 2(3): 287-298 (2002).
Ishikawa et al., Pharmacokinetics of Acetaminophen from Rapildy Disintegrating Compressed Tablet Prepared Using Microcrystalline Celluose (PH-M-06) and Spherical Sugar Granules1),Chem. Pharm. Bull. (Tokyo), 49: 230-232 (2001).
Laumann et al., Sexual Dysfunction in the United States: Prevalence and Predictors,JAMA, 281: 537-544 (1999).
Looney et al., Differential effects of simultaneous or sequential administration of paroxetine and WAY-100,635 on ejaculatory behavior,Pharmacol. Biochem., 82: 427-433 (2005).
Pattij et al., Animal Models of Ejaculatory Behavior,Curr. Pharm. Des., 11(31): 4069-4077 (2005).
Price et al., Single-Dose Pharmacokinetics of Sublingual Versus Oral Administration of Micronized 17β-Estradiol,Obstet. Gynecol., 89: 340-345 (1997).
Prisinzano et al., Synthesis and determination of the absolute configuration of the enantiomers of modafinil,Tetrahedron: Asymmetry, 15: 1053-1058 (2004).
PROVIGIL® Patient Information Leaflet (Cephalon, Inc., West Chester, PA, 2004).
Rapid-Dissolve Technology: An Interview with Loyd V. Allen, Jr., PhD, RPh,International Journal of Pharmaceutical Compounding, 7(6): 449-450 (2003).
Robertson et al., Clinical Pharmacokinetic Profile of Modafinil,Clin. Pharmacokinet., 42: 123-137 (2003).
Salamat-Miller et al., The use of mucoadhesive polymers in buccal drug delivery,Adv. Drug Deliv. Rev., 57(11): 1666-1691 (2005).
Saletu et al., Differential Effects of a New Central Adrenergic Agonist—Modafinil—and D-Amphetamine on Sleep and Early Morning Behaviour in Young Healthy Volunteers,Int. J. Clin. Pharm. Res., 9: 183-195 (1989).
Sharlip, J., Diagnosis and Treatment of Premature Ejaculation: The Physician's Perspective,J. Sex. Med. Supp., 2: 103-109 (2005).
Smart, The basics and underlying mechanisms of mucoadhesion,Adv. Drug Deliv. Rev., 57(11): 1556-1568 (2005).
Türker et al., Nasal route and drug delivery systems,Pharm. World Sci., 26(3): 137-142 (2004).
Ugwoke et al., Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives,Adv. Drug Deliv. Rev., 57(11): 1640-1650 (2005).
Waldinger, Lifelong premature ejaculation: definition, serotonergic neurotransmission and drug treatment,World J. Urol., 23(2): 115-118 (2005).
Watanbe et al., New Compressed Tablet Rapildy Disintegrating in Saliva in the Mouth Using Crystalline Cellulose and a Disintegrant,Biol. Pharm. Bull., 18: 1308-1310 (1995).
Wisor et al., Dopaminergic role in Stimulant-Induced Wakefulness,J. Neuroscience, 21(5): 1787-1794 (2001).
Wong et al., A Double-Blind, Placebo-Controlled, Ascending-Dose Evaluation of the Pharmacokinetics and Tolerability of Modafinil Tablets in Healthy Male Volunteers,J. Clin. Pharmacol., 39: 30-40 (1999).
Wong et al., Open-Label, Single-Dose Pharmacokinetic Study of Modafinil Tablets: Influence of Age and Gender in Normal Subjects,J. Clin. Pharmacol., 39: 281-288 (1999).
Woodley, J., Bioadhesion,Clin. Pharmacokinet., 40(2): 77-84 (2001).
EPO Communication dated Nov. 17, 2009, enclosing Extended European Search Report, supplemental EP search report, and the EP search opinion dated Nov. 5, 2009, issued in EP Application No. 07 811305.7.
EPO Communication pursuant to Article 94(3) EPC dated Jan. 29, 2010, issued in EP application No. 07 811305.7, with attached European Search Opinion and Supplementary European Search Report dated Nov. 5, 2009.
Marson et al., “Effects of NHO2D on Ejaculation Latency and Sexual Behavior in Rats”, The Journal of Urology, 181(4) Supplement: 241 (Abstract No. 672) (Apr. 27, 2009).
Marson et al., “The Effects of Oral Administration of D-Modafinil on Male Rat Ejaculatory Behavior”, J. of Sex. Med., vol. 7, Issue 1, pt 1: 70-78 (2009).
Waldinger, M.D., “Use of Psychoactive Agents in the Treatment of Sexual Dysfunction”, CNS Drugs, 6(3): 204-216 (1996).
Hui San-ming
NeuroHealing Pharmaceuticals, Inc.
O'Brien David G.
Yankwich Leon R.
Yankwich & Associates P.C.
LandOfFree
Modafinil-based treatment for premature ejaculation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modafinil-based treatment for premature ejaculation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modafinil-based treatment for premature ejaculation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2649201